Sands, Bruce E.

STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD

Turner, D., Ricciuto, A., Lewis, A., D’Amico, F., Dhaliwal, J., Griffiths, A. M., Bettenworth, D., Sandborn, W. J., Sands, B. E., Reinisch, W., et al. (2021) · Gastroenterology

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 2,911

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., et al. (2012) · Genome Biology

Gut microbiota and healthInflammatory Bowel Disease

Cited by 2,713

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn’s disease: unexpected results of a randomised, double-blind placebo-controlled trial

Hueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut

Inflammatory Bowel DiseasePsoriasis: Treatment and Pathogenesis

Cited by 1,547

Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice

Britton, G. J., Contijoch, E. J., Mogno, I., Vennaro, O. H., Llewellyn, S. R., Ng, R., Li, Z., Mortha, A., Merad, M., Das, A., et al. (2019) · Immunity

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 549

Sex-Based Differences in Incidence of Inflammatory Bowel Diseases—Pooled Analysis of Population-Based Studies From Western Countries

Shah, S. C., Khalili, H., Gower-Rousseau, C., Olen, O., Benchimol, E. I., Lynge, E., Nielsen, K. R., Brassard, P., Vutcovici, M., Bitton, A., et al. (2018) · Gastroenterology

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 286

Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study

Sands, B. E., Chen, J., Feagan, B. G., Penney, M., Rees, W. A., Danese, S., Higgins, P. D. R., Newbold, P., Faggioni, R., Patra, K., et al. (2017) · Gastroenterology

Inflammatory Bowel DiseasePsoriasis: Treatment and Pathogenesis

Cited by 279

American Gastroenterological Association Consensus Development Conference on the Use of Biologics in the Treatment of Inflammatory Bowel Disease, June 21–23, 2006

Clark, M., Colombel, J.-F., Feagan, B. C., Fedorak, R. N., Hanauer, S. B., Kamm, M. A., Mayer, L., Regueiro, C., Rutgeerts, P., Sandborn, W. J., et al. (2007) · Gastroenterology

Inflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies

Cited by 224

Converging goals of treatment of inflammatory bowel disease from clinical trials and practice

Levesque, B. G., Sandborn, W. J., Ruel, J., Feagan, B. G., Sands, B. E., & Colombel, J.-F. (2015) · Gastroenterology

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 217

Occurrence of Colon Ischemia in Relation to Irritable Bowel Syndrome

Cole, J. A., Cook, S. F., Sands, B. E., Ajene, A. N., Miller, D. P., & Walker, A. M. (2004) · American Journal of Gastroenterology

Abdominal vascular conditions and treatmentsGastrointestinal motility and disorders

Cited by 121

Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn’s disease

Sands, B. E., Jacobson, E. W., Sylwestrowicz, T., Younes, Z., Dryden, G., Fedorak, R., & Greenbloom, S. (2010) · Inflammatory Bowel Diseases

Inflammatory Bowel DiseasePsoriasis: Treatment and Pathogenesis

Cited by 114

An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials

Ma, C., Sedano, R., Almradi, A., Vande Casteele, N., Parker, C. E., Guizzetti, L., Schaeffer, D. F., Riddell, R. H., Pai, R. K., Battat, R., et al. (2021) · Gastroenterology

Inflammatory Bowel DiseaseMicroscopic Colitis

Cited by 105

Longitudinal Autonomic Nervous System Measures Correlate With Stress and Ulcerative Colitis Disease Activity and Predict Flare

Hirten, R. P., Danieletto, M., Scheel, R., Shervey, M., Ji, J., Hu, L., Sauk, J., Chang, L., Arnrich, B., Bӧttinger, E., et al. (2021) · Inflammatory Bowel Diseases

Inflammatory Bowel DiseaseHeart Rate Variability and Autonomic Control

Cited by 60

The SCENIC consensus statement on surveillance and management of dysplasia in inflammatory bowel disease: praise and words of caution

Marion, J. F., & Sands, B. E. (2015) · Gastroenterology

Inflammatory Bowel DiseaseColorectal Cancer Screening and Detection

Cited by 50

Body Image Dissatisfaction in Patients with Inflammatory Bowel Disease

Saha, S., Zhao, Y.-Q., Shah, S. A., Esposti, S. D., Lidofsky, S., Bright, R., Law, M., Moniz, H., Samad, Z., Merrick, M., et al. (2015) · Inflammatory Bowel Diseases

Inflammatory Bowel DiseaseBody Image and Dysmorphia Studies

Cited by 39

Challenges and opportunities in IBD clinical trial design

Dubinsky, M. C., Collins, R., Abreu, M. T., Abreu, M. T., Collins, R., Dubinsky, M. C., Jairath, V., Lewis, J. D., Lindsay, J., Merad, M., et al. (2021) · Gastroenterology

Inflammatory Bowel DiseaseStatistical Methods in Clinical Trials

Cited by 34

The Placebo Response Rate in Irritable Bowel Syndrome and Inflammatory Bowel Disease

Sands, B. E. (2009) · Digestive Diseases

Pain Management and Placebo EffectInflammatory Bowel Disease

Cited by 17